Oropharyngeal Candidiasis (OPC) and S-ECC
Temple University · with Children's Hospital of Philadelphia · NCT05761197
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 10 mo–1 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 70
- US sites recruiting
- 1
- Study start
- September 1, 2024
- Record last updated
- June 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall objective of this study is to investigate the association of early Candida infection (known as oral thrush or oropharyngeal candidiasis, OPC) in children during the first year of life with the onset and severity of severe early childhood caries (S-ECC).
Conditions: Candida Infection; Oral Thrush; Early Childhood Caries
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male or female individuals at the age of 9-15-month-old
- Must have at least one fully erupted tooth at baseline visit
- Parent/guardian willing and able to provide informed consent
- With or without a history of OPC (the study team will enroll 35 participants with and 35 participants without a history of OPC)
Exclusion Criteria
- Presence of a systemic medical condition (e.g. Down syndrome etc.)
- Presence of an orofacial deformity
- Presence of dental caries
- Use of systemic antimicrobial therapy within 30 days of the baseline visit
- Presence of any condition which, in the opinion of the investigator, makes participation in the project not in the individual's best interest.
Recruiting US locations
Temple University
Philadelphia, PA 19140
Site contact: Yuan Liu, DDS, MS, PhD · 215-707-8029 · ksodtres@temple.edu
Study contacts (from the official record)
- Yuan Liu, DDS, MS, PhD · 215-707-8029 · yuan.liu0008@temple.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only